Related Experiment Videos
Hemophagocytic lymphohistiocytosis after chemotherapy for multiple myeloma
John V Terrovitis1, Charis Matsouka, Athanassios Anagnostopoulos
1University of Athens School of Medicine, Department of Clinical Therapeutics, Alexandra Hospital, Greece. iterr@otenet.gr
Clinical Lymphoma
|January 8, 2005
Abstract:
Secondary hemophagocytic lymphohistiocytosis has been reported after infections in immunocompromised hosts or in association with several malignancies. We report a case of secondary hemophagocytic syndrome after chemotherapy for multiple myeloma, which responded dramatically to dexamethasone, etoposide, and cyclosporin A.